The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
Sutherland Asbill & Brennan LLP, Atlanta, GA, USA.
Devesh
D
Srivastava
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D006801:Humans; D017387:Investigational New Drug Application / Q000331:legislation & jurisprudence; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D013810:Therapeutic Equivalency; D014481:United States; D014485:United States Federal Trade Commission; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*
D016568:Drugs, Generic